AaronWPardiniMD(He/Him)
Endocrinology • Santa Cruz, CADiabetes, Lipid Metabolism, Thyroid
Staff Endocrinologist-Dignity Health
Dr. Pardini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1595 Soquel Dr Unit 411
Santa Cruz, CA 95060
Summary
- Dr. Aaron Pardini is an endocrinologist in Oakland, CA and is affiliated with multiple hospitals in the area, including Highland Hospital and Alameda County Medical Center - Fairmont. He received his medical degree from American University of the Caribbean School of Medicine and has been in practice 17 years. He specializes in diabetes, lipid metabolism, and thyroid and is experienced in general endocrinology, diabetes mellitus, arcuate nucleus, and energy metabolism.
Education & Training
University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 2006
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2000 - 2003
American University of the Caribbean School of MedicineClass of 2000
Certifications & Licensure
OR State Medical License 2006 - Present
CA State Medical License 2012 - 2026
OH State Medical License 2022 - 2024
WA State Medical License 2003 - 2007- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy Start of enrollment: 2008 Feb 01
- Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2 Start of enrollment: 2010 May 17
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4) Start of enrollment: 2010 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 412 citations3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W. le Roux, Arne Astrup, Ken Fujioka, Frank Greenway, David C.W. Lau
Lancet. 2017-04-08 - 67 citationsDistribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis.Aaron W. Pardini, Hong T. Nguyen, Dianne P. Figlewicz, Denis G. Baskin, Diana L. Williams
Brain Research. 2006-09-27 - 57 citationsDeficiency of TNFα Converting Enzyme (TACE/ADAM17) Causes a Lean, Hypermetabolic Phenotype in MiceRichard W. Gelling, Wenbo Yan, Salwa Al-Noori, Aaron W. Pardini, Gregory J. Morton
Endocrinology. 2008-08-07
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
